In this review, Sahebkar et al. summarize the current knowledge on the contribution of the NLRP3 inflammasome on potential cancer promotion and therapy.
Christophe Nicot, Kansas University Medical Center, USA
Aims and scope
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Annual Journal Metrics
59 days to first decision for reviewed manuscripts only
49 days to first decision for all manuscripts
121 days from submission to acceptance
17 days from acceptance to publication
10.679 - 2-year Impact Factor
7.898 - 5-year Impact Factor
1.967 - Source Normalized Impact per Paper (SNIP)
3.274 - SCImago Journal Rank (SJR)
352 Altmetric mentions